These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15565916)

  • 1. Preclinical studies on detection of circulating melanoma cells in patients: telomerase as a recognition marker of malignancy.
    Bonmassar L; Massara MC; Cottarelli A; Aquino A; Formica V; Prete SP; Lacal PM; Marchetti P; Concolino F; Faraoni I; D'Atri S
    J Chemother; 2004 Oct; 16(5):479-86. PubMed ID: 15565916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of circulating melanoma cells by immunomagnetic cell sorting.
    Benez A; Geiselhart A; Handgretinger R; Schiebel U; Fierlbeck G
    J Clin Lab Anal; 1999; 13(5):229-33. PubMed ID: 10494132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.
    Soria JC; Gauthier LR; Raymond E; Granotier C; Morat L; Armand JP; Boussin FD; Sabatier L
    Clin Cancer Res; 1999 May; 5(5):971-5. PubMed ID: 10353728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologically intact melanoma cells may be detected in peripheral blood of melanoma patients.
    Benez A; Schiebel U; Fierlbeck G
    Recent Results Cancer Res; 2001; 158():113-7. PubMed ID: 11092038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic role of detection of circulating melanoma cells in the blood.
    Dutcher JP
    J Clin Oncol; 2003 Mar; 21(5):757-9. PubMed ID: 12610168
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of telomerase-positive circulating epithelial cells in ovarian cancer patients.
    Sapi E; Okpokwasili NI; Rutherford T
    Cancer Detect Prev; 2002; 26(2):158-67. PubMed ID: 12102151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating carcinoma cells by telomerase activity.
    Gauthier LR; Granotier C; Soria JC; Faivre S; Boige V; Raymond E; Boussin FD
    Br J Cancer; 2001 Mar; 84(5):631-5. PubMed ID: 11237383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance.
    Khoja L; Lorigan P; Dive C; Keilholz U; Fusi A
    Ann Oncol; 2015 Jan; 26(1):33-39. PubMed ID: 24907634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction.
    Guo J; Xiao B; Jin Z; Qin L; Chen J; Chen H; Zhang X; Liu Z
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1279-84. PubMed ID: 16048578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating biomarkers in malignant melanoma.
    Alegre E; Sammamed M; Fernández-Landázuri S; Zubiri L; González Á
    Adv Clin Chem; 2015; 69():47-89. PubMed ID: 25934359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity in prognostic histopathologic features of melanoma.
    Carvalho L; Lipay M; Belfort F; Santos I; Andrade J; Haddad A; Brunstein F; Ferreira L
    J Plast Reconstr Aesthet Surg; 2006; 59(9):961-8. PubMed ID: 16920589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular markers of circulating melanoma cells.
    Medic S; Pearce RL; Heenan PJ; Ziman M
    Pigment Cell Res; 2007 Apr; 20(2):80-91. PubMed ID: 17371435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-situ hybridization-based quantification of hTR: a possible biomarker in malignant melanoma.
    Vagner J; Steiniche T; Stougaard M
    Histopathology; 2015 Apr; 66(5):747-51. PubMed ID: 25601620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular detection of circulating tumor cells in bladder cancer using telomerase activity.
    Soria JC; Morat L; Durdux C; Housset M; Cortez A; Blaise R; Sabatier L
    J Urol; 2002 Jan; 167(1):352-6. PubMed ID: 11743355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
    Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
    Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.
    Novakovic S; Hocevar M; Zgajnar J; Besic N; Stegel V
    Oncol Rep; 2004 Jan; 11(1):245-52. PubMed ID: 14654933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation.
    Waguri N; Suda T; Nomoto M; Kawai H; Mita Y; Kuroiwa T; Igarashi M; Kobayashi M; Fukuhara Y; Aoyagi Y
    Clin Cancer Res; 2003 Aug; 9(8):3004-11. PubMed ID: 12912949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumour cells and circulating endothelial cells as biomarkers in oncology.
    Strijbos MH
    Acta Clin Belg; 2011; 66(5):332-6. PubMed ID: 22145267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma.
    Palmieri G; Satriano SM; Budroni M; Cossu A; Tanda F; Canzanella S; Caracò C; Simeone E; Daponte A; Mozzillo N; Comella G; Castello G; Ascierto PA
    BMC Cancer; 2006 Nov; 6():266. PubMed ID: 17107608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating melanoma cells and survival in metastatic melanoma.
    Rao C; Bui T; Connelly M; Doyle G; Karydis I; Middleton MR; Clack G; Malone M; Coumans FA; Terstappen LW
    Int J Oncol; 2011 Mar; 38(3):755-60. PubMed ID: 21206975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.